CDT Key Statistics, Chart & Performance
The current stock price of CDT is 1.33 USD. In the past month the price decreased by -30.05%. In the past year, price decreased by -99.83%.
CDT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 26.04 | 219.12B | ||
| DHR | DANAHER CORP | 29.93 | 163.00B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 187.31 | 56.92B | ||
| A | AGILENT TECHNOLOGIES INC | 24.64 | 38.97B | ||
| IQV | IQVIA HOLDINGS INC | 19.61 | 38.84B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 33.77 | 28.86B | ||
| WAT | WATERS CORP | 30.17 | 22.81B | ||
| ILMN | ILLUMINA INC | 30.5 | 20.32B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 39.24 | 19.96B | ||
| MEDP | MEDPACE HOLDINGS INC | 39.99 | 16.11B | ||
| RVTY | REVVITY INC | 20.37 | 11.06B | ||
| TEM | TEMPUS AI INC | N/A | 10.71B |
Related stock screener links
About CDT
Company Profile
CDT Equity Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. CDT Equity Inc., formerly Conduit Pharmaceuticals, Inc. is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.
Company Info
CDT EQUITY INC
4851 Tamiami Trail North, Suite 200
Naples Florida FLORIDA US
Employees: 6
Phone: 16464919132
CDT EQUITY INC / CDT FAQ
What does CDT do?
CDT Equity Inc is a US-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Naples Florida, Florida and currently employs 6 full-time employees. The company went IPO on 2022-02-03. CDT Equity Inc., formerly Conduit Pharmaceuticals, Inc. is a data-driven biotech development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. Through advanced co-crystallization and solidform technologies developed at its Cambridge facility, it is engaged in improving drug properties and has helped in extending the patent life of certain drugs by up to 20 years. Its pipeline includes candidates targeting inflammatory and autoimmune disorders, as well as idiopathic male infertility, dermatology and animal health. The company applies proprietary algorithms utilizing AI-powered disease mapping to identify novel repurposing opportunities against a database of over 800 disease signatures. In addition, the Company has initiated pre-clinical in-vitro models to explore new indications, guided by AI-insights without human intervention.
What is the stock price of CDT EQUITY INC today?
The current stock price of CDT is 1.33 USD. The price decreased by -6.34% in the last trading session.
Does CDT EQUITY INC pay dividends?
CDT does not pay a dividend.
What is the ChartMill rating of CDT EQUITY INC stock?
CDT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is CDT stock listed?
CDT stock is listed on the Nasdaq exchange.
What is the market capitalization of CDT stock?
CDT EQUITY INC (CDT) has a market capitalization of 2.17M USD. This makes CDT a Nano Cap stock.
What is the ownership structure of CDT EQUITY INC (CDT)?
You can find the ownership structure of CDT EQUITY INC (CDT) on the Ownership tab.
CDT Technical Analysis
CDT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CDT. CDT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
CDT Financial Highlights
Over the last trailing twelve months CDT reported a non-GAAP Earnings per Share(EPS) of -473.65. The EPS increased by 47.46% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -242.03% | ||
| ROE | -483.82% | ||
| Debt/Equity | 0 |